Rare lephants
Screener

Fulcrum Therapeutics, Inc.

FULC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 17, 2023 8-K
4 Jan 13, 2023 FORM 4 SUBMISSION
4 Jan 6, 2023 OWNERSHIP DOCUMENT
SC 13G/A Jan 6, 2023 SC 13G/A
8-K Jan 4, 2023 8-K
4 Dec 29, 2022 OWNERSHIP DOCUMENT
4 Dec 21, 2022 OWNERSHIP DOCUMENT
4 Dec 16, 2022 OWNERSHIP DOCUMENT
4 Dec 15, 2022 FORM 4 SUBMISSION
4 Nov 9, 2022 FORM 4 SUBMISSION
3 Nov 9, 2022 FORM 3 SUBMISSION
10-Q Nov 8, 2022 10-Q
8-K Nov 8, 2022 8-K
8-K Oct 19, 2022 8-K
3 Aug 26, 2022 OWNERSHIP DOCUMENT
SC 13G Aug 26, 2022 FULCRUM THERAPEUTICS, INC.
8-K Aug 23, 2022 8-K
8-K Aug 17, 2022 8-K
424B5 Aug 17, 2022 424B5
424B5 Aug 15, 2022 424B5
4 Aug 11, 2022 FORM 4 SUBMISSION
4 Aug 11, 2022 FORM 4 SUBMISSION
3 Aug 11, 2022 FORM 3 SUBMISSION
10-Q Aug 11, 2022 10-Q
8-K Aug 11, 2022 8-K
← Newer Page 10 of 21 · 514 filings Older →